Scarica l'app Stockscreener
77.00
0.17%
0.13
Pre-mercato:
77.69
0.69
+0.90%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NFLX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$76.87
Aprire:
$76.92
Volume 24 ore:
35.88M
Relative Volume:
0.78
Capitalizzazione di mercato:
$325.11B
Reddito:
$45.27B
Utile/perdita netta:
$10.98B
Rapporto P/E:
30.47
EPS:
2.5272
Flusso di cassa netto:
$9.46B
1 W Prestazione:
-6.34%
1M Prestazione:
-12.50%
6M Prestazione:
-37.85%
1 anno Prestazione:
-27.26%
Intervallo 1D:
$75.30
$77.87
Intervallo di 1 settimana:
$75.23
$82.48
Portata 52W:
$75.23
$134.12
Netflix Inc Stock (NFLX) Company Profile
Nome
Netflix Inc
Settore
Industria
Telefono
408-540-3700
Indirizzo
121 ALBRIGHT WAY, LOS GATOS
Compare NFLX vs DIS, WBD, LYV, FOXA
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NFLX
Netflix Inc
|
77.00 | 324.56B | 45.27B | 10.98B | 9.46B | 2.5272 |
|
DIS
Walt Disney Co
|
105.44 | 186.81B | 95.62B | 13.27B | 7.06B | 6.7872 |
|
WBD
Warner Bros Discovery Inc
|
28.75 | 69.40B | 37.87B | 356.00M | 4.13B | 0.1876 |
|
LYV
Live Nation Entertainment Inc
|
157.53 | 36.75B | 24.57B | 532.09M | 1.59B | 1.37 |
|
FOXA
Fox Corporation
|
56.43 | 23.97B | 16.47B | 2.07B | 2.67B | 4.4433 |
Netflix Inc Stock (NFLX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-23 | Reiterato | Robert W. Baird | Outperform |
| 2026-01-21 | Reiterato | BMO Capital Markets | Outperform |
| 2026-01-21 | Reiterato | Canaccord Genuity | Buy |
| 2026-01-21 | Reiterato | Deutsche Bank | Hold |
| 2026-01-21 | Reiterato | Goldman | Neutral |
| 2026-01-21 | Reiterato | Guggenheim | Buy |
| 2026-01-21 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2026-01-21 | Reiterato | Morgan Stanley | Overweight |
| 2026-01-21 | Reiterato | Needham | Buy |
| 2026-01-21 | Reiterato | Oppenheimer | Outperform |
| 2026-01-21 | Reiterato | Piper Sandler | Overweight |
| 2026-01-21 | Reiterato | Pivotal Research Group | Hold |
| 2026-01-21 | Reiterato | Rosenblatt | Neutral |
| 2026-01-21 | Reiterato | Rothschild & Co Redburn | Buy |
| 2026-01-21 | Reiterato | TD Cowen | Buy |
| 2026-01-21 | Reiterato | UBS | Buy |
| 2026-01-21 | Reiterato | Wolfe Research | Outperform |
| 2026-01-12 | Iniziato | HSBC Securities | Buy |
| 2026-01-09 | Reiterato | Goldman | Neutral |
| 2025-12-08 | Downgrade | Pivotal Research Group | Buy → Hold |
| 2025-12-08 | Downgrade | Rosenblatt | Buy → Neutral |
| 2025-11-18 | Reiterato | Barclays | Equal Weight |
| 2025-10-31 | Downgrade | Erste Group | Buy → Hold |
| 2025-10-07 | Aggiornamento | Seaport Research Partners | Neutral → Buy |
| 2025-09-17 | Aggiornamento | Loop Capital | Hold → Buy |
| 2025-07-10 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2025-07-07 | Downgrade | Seaport Research Partners | Buy → Neutral |
| 2025-07-02 | Reiterato | Canaccord Genuity | Buy |
| 2025-07-02 | Reiterato | Goldman | Neutral |
| 2025-06-20 | Reiterato | Pivotal Research Group | Buy |
| 2025-06-12 | Reiterato | Oppenheimer | Outperform |
| 2025-06-03 | Reiterato | Jefferies | Buy |
| 2025-05-30 | Reiterato | BofA Securities | Buy |
| 2025-05-19 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-04-21 | Reiterato | BMO Capital Markets | Outperform |
| 2025-04-21 | Reiterato | Barclays | Equal Weight |
| 2025-04-21 | Reiterato | Canaccord Genuity | Buy |
| 2025-04-21 | Reiterato | Guggenheim | Buy |
| 2025-04-21 | Reiterato | JP Morgan | Overweight |
| 2025-04-21 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2025-04-21 | Reiterato | MoffettNathanson | Buy |
| 2025-04-21 | Reiterato | Morgan Stanley | Overweight |
| 2025-04-21 | Reiterato | Oppenheimer | Outperform |
| 2025-04-21 | Reiterato | Piper Sandler | Overweight |
| 2025-04-21 | Reiterato | Pivotal Research Group | Buy |
| 2025-04-21 | Reiterato | Wells Fargo | Overweight |
| 2025-04-17 | Ripresa | Piper Sandler | Overweight |
| 2025-03-27 | Iniziato | FBN Securities | Outperform |
| 2025-03-17 | Aggiornamento | MoffettNathanson | Neutral → Buy |
| 2025-01-24 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2025-01-23 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-01-22 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2025-01-22 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2025-01-22 | Reiterato | Oppenheimer | Outperform |
| 2025-01-22 | Reiterato | Pivotal Research Group | Buy |
| 2025-01-22 | Aggiornamento | Rosenblatt | Neutral → Buy |
| 2025-01-22 | Aggiornamento | The Benchmark Company | Sell → Hold |
| 2025-01-16 | Aggiornamento | Seaport Research Partners | Neutral → Buy |
| 2025-01-15 | Reiterato | BMO Capital Markets | Outperform |
| 2025-01-15 | Reiterato | Oppenheimer | Outperform |
| 2025-01-08 | Reiterato | Goldman | Neutral |
| 2025-01-06 | Reiterato | Argus | Buy |
| 2025-01-03 | Reiterato | The Benchmark Company | Sell |
| 2024-12-19 | Reiterato | UBS | Buy |
| 2024-12-16 | Downgrade | Loop Capital | Buy → Hold |
| 2024-12-16 | Reiterato | Oppenheimer | Outperform |
| 2024-12-11 | Reiterato | JP Morgan | Overweight |
| 2024-11-20 | Reiterato | Pivotal Research Group | Buy |
| 2024-10-18 | Reiterato | Needham | Buy |
| 2024-10-18 | Reiterato | Oppenheimer | Outperform |
| 2024-10-18 | Reiterato | Pivotal Research Group | Buy |
| 2024-10-16 | Reiterato | Loop Capital | Buy |
| 2024-10-11 | Reiterato | Guggenheim | Buy |
| 2024-10-10 | Reiterato | Morgan Stanley | Overweight |
| 2024-10-10 | Reiterato | Oppenheimer | Outperform |
| 2024-10-07 | Downgrade | Barclays | Equal Weight → Underweight |
| 2024-10-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-10-01 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2024-09-05 | Iniziato | China Renaissance | Hold |
| 2024-08-30 | Reiterato | Pivotal Research Group | Buy |
| 2024-07-17 | Reiterato | Guggenheim | Buy |
| 2024-07-16 | Reiterato | The Benchmark Company | Sell |
| 2024-07-15 | Reiterato | BofA Securities | Buy |
| 2024-07-12 | Reiterato | JP Morgan | Overweight |
| 2024-07-10 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2024-07-09 | Reiterato | TD Cowen | Buy |
| 2024-07-02 | Reiterato | Argus | Buy |
| 2024-05-28 | Reiterato | Evercore ISI | Outperform |
| 2024-04-19 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2024-04-19 | Aggiornamento | Needham | Hold → Buy |
| 2024-04-19 | Reiterato | Pivotal Research Group | Buy |
| 2024-04-15 | Reiterato | Deutsche Bank | Hold |
| 2024-04-12 | Reiterato | Morgan Stanley | Overweight |
| 2024-04-12 | Reiterato | Piper Sandler | Neutral |
| 2024-04-05 | Reiterato | Pivotal Research Group | Buy |
| 2024-03-25 | Reiterato | Citigroup | Neutral |
| 2024-03-12 | Reiterato | Jefferies | Buy |
| 2024-03-11 | Reiterato | Oppenheimer | Outperform |
| 2024-01-30 | Downgrade | Seaport Research Partners | Buy → Neutral |
| 2024-01-25 | Aggiornamento | DZ Bank | Hold → Buy |
| 2024-01-24 | Reiterato | BMO Capital Markets | Outperform |
| 2024-01-24 | Reiterato | BofA Securities | Buy |
| 2024-01-24 | Reiterato | Canaccord Genuity | Buy |
| 2024-01-24 | Reiterato | Evercore ISI | Outperform |
| 2024-01-24 | Reiterato | Goldman | Neutral |
| 2024-01-24 | Reiterato | Guggenheim | Buy |
| 2024-01-24 | Reiterato | JP Morgan | Overweight |
| 2024-01-24 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2024-01-24 | Aggiornamento | Macquarie | Neutral → Outperform |
| 2024-01-24 | Reiterato | Morgan Stanley | Overweight |
| 2024-01-24 | Reiterato | Oppenheimer | Outperform |
| 2024-01-24 | Reiterato | Piper Sandler | Neutral |
| 2024-01-24 | Reiterato | Pivotal Research Group | Buy |
| 2024-01-24 | Reiterato | Redburn Atlantic | Buy |
| 2024-01-24 | Reiterato | Robert W. Baird | Outperform |
| 2024-01-24 | Reiterato | TD Cowen | Outperform |
| 2024-01-24 | Reiterato | UBS | Buy |
| 2024-01-24 | Reiterato | Wells Fargo | Overweight |
| 2023-09-18 | Reiterato | Evercore ISI | Outperform |
| 2023-08-25 | Aggiornamento | Loop Capital | Hold → Buy |
| 2023-07-24 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2023-07-17 | Reiterato | Deutsche Bank | Buy |
| 2023-07-13 | Reiterato | JP Morgan | Overweight |
| 2023-07-12 | Reiterato | UBS | Buy |
| 2023-07-05 | Aggiornamento | Goldman | Sell → Neutral |
| 2023-06-29 | Reiterato | Citigroup | Buy |
| 2023-06-28 | Reiterato | Oppenheimer | Outperform |
| 2023-06-13 | Reiterato | BofA Securities | Buy |
| 2023-06-13 | Reiterato | Guggenheim | Buy |
| 2023-04-19 | Reiterato | Deutsche Bank | Buy |
| 2023-04-19 | Reiterato | JP Morgan | Overweight |
| 2023-04-19 | Reiterato | Jefferies | Buy |
| 2023-04-19 | Reiterato | Piper Sandler | Neutral |
| 2023-04-19 | Reiterato | Pivotal Research Group | Buy |
| 2023-04-19 | Reiterato | Rosenblatt | Neutral |
| 2023-04-19 | Aggiornamento | UBS | Neutral → Buy |
| 2023-04-11 | Ripresa | Robert W. Baird | Neutral |
| 2023-01-23 | Reiterato | Argus | Buy |
| 2023-01-20 | Reiterato | Canaccord Genuity | Buy |
| 2023-01-20 | Reiterato | Deutsche Bank | Buy |
| 2023-01-20 | Reiterato | Evercore ISI | Outperform |
| 2023-01-20 | Reiterato | Goldman | Sell |
| 2023-01-20 | Reiterato | Guggenheim | Buy |
| 2023-01-20 | Reiterato | Jefferies | Buy |
| 2023-01-20 | Reiterato | MoffettNathanson | Market Perform |
| 2023-01-20 | Reiterato | Oppenheimer | Outperform |
| 2023-01-20 | Reiterato | Piper Sandler | Neutral |
| 2023-01-20 | Reiterato | Pivotal Research Group | Buy |
| 2023-01-20 | Reiterato | Robert W. Baird | Neutral |
| 2023-01-20 | Reiterato | The Benchmark Company | Sell |
| 2023-01-20 | Reiterato | Wedbush | Outperform |
| 2023-01-20 | Reiterato | Wolfe Research | Outperform |
| 2023-01-12 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-01-04 | Iniziato | New Street | Neutral |
| 2022-12-29 | Aggiornamento | CFRA | Sell → Buy |
| 2022-12-14 | Reiterato | Jefferies | Hold |
| 2022-12-09 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-06-14 | Downgrade | The Benchmark Company | Hold → Sell |
| 2022-06-10 | Downgrade | Goldman | Neutral → Sell |
| 2022-05-16 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2022-04-21 | Downgrade | DZ Bank | Buy → Hold |
| 2022-04-21 | Downgrade | Edward Jones | Buy → Hold |
| 2022-04-20 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-04-20 | Downgrade | BofA Securities | Buy → Underperform |
| 2022-04-20 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-04-20 | Aggiornamento | Needham | Underperform → Hold |
| 2022-04-20 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-04-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Downgrade | Pivotal Research Group | Buy → Sell |
| 2022-04-20 | Downgrade | Stifel | Buy → Hold |
| 2022-04-20 | Downgrade | UBS | Buy → Neutral |
| 2022-04-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-19 | Iniziato | Rosenblatt | Neutral |
| 2022-03-09 | Aggiornamento | Wedbush | Underperform → Neutral |
| 2022-01-31 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-01-31 | Aggiornamento | Edward Jones | Hold → Buy |
| 2022-01-24 | Downgrade | Jefferies | Buy → Hold |
| 2022-01-21 | Reiterato | BMO Capital Markets | Outperform |
| 2022-01-21 | Reiterato | BofA Securities | Buy |
| 2022-01-21 | Reiterato | Canaccord Genuity | Buy |
| 2022-01-21 | Reiterato | Cowen | Outperform |
| 2022-01-21 | Reiterato | Deutsche Bank | Hold |
| 2022-01-21 | Reiterato | Goldman | Neutral |
| 2022-01-21 | Reiterato | Guggenheim | Buy |
| 2022-01-21 | Reiterato | JP Morgan | Overweight |
| 2022-01-21 | Reiterato | MoffettNathanson | Neutral |
| 2022-01-21 | Downgrade | Monness Crespi & Hardt | Buy → Neutral |
| 2022-01-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-21 | Reiterato | Oppenheimer | Outperform |
| 2022-01-21 | Reiterato | Piper Sandler | Overweight |
| 2022-01-21 | Reiterato | Pivotal Research Group | Buy |
| 2022-01-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-01-21 | Reiterato | Stifel | Buy |
| 2022-01-21 | Aggiornamento | The Benchmark Company | Sell → Hold |
| 2022-01-21 | Downgrade | Truist | Buy → Hold |
| 2022-01-21 | Reiterato | UBS | Buy |
| 2022-01-21 | Reiterato | Wolfe Research | Outperform |
| 2021-12-15 | Reiterato | The Benchmark Company | Sell |
| 2021-10-20 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-10-20 | Reiterato | Monness Crespi & Hardt | Buy |
| 2021-09-29 | Reiterato | The Benchmark Company | Sell |
| 2021-09-13 | Iniziato | Goldman | Neutral |
| 2021-09-08 | Reiterato | JP Morgan | Overweight |
| 2021-09-07 | Reiterato | Atlantic Equities | Overweight |
| 2021-07-21 | Reiterato | Credit Suisse | Outperform |
| 2021-07-21 | Reiterato | Deutsche Bank | Buy |
| 2021-07-21 | Reiterato | JP Morgan | Overweight |
| 2021-07-21 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2021-07-21 | Reiterato | Stifel | Buy |
| 2021-06-25 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2021-06-25 | Iniziato | Edward Jones | Hold |
| 2021-05-19 | Ripresa | Jefferies | Buy |
| 2021-04-21 | Ripresa | Oppenheimer | Outperform |
| 2021-04-21 | Reiterato | Pivotal Research Group | Buy |
| 2021-04-21 | Aggiornamento | Stifel | Hold → Buy |
| 2021-04-06 | Ripresa | Evercore ISI | Outperform |
| 2021-04-01 | Iniziato | Piper Sandler | Overweight |
| 2021-03-25 | Reiterato | The Benchmark Company | Sell |
| 2021-03-23 | Aggiornamento | Argus | Hold → Buy |
| 2021-01-21 | Aggiornamento | DZ Bank | Hold → Buy |
| 2021-01-20 | Reiterato | Monness Crespi & Hardt | Buy |
| 2021-01-20 | Reiterato | Pivotal Research Group | Buy |
| 2021-01-20 | Reiterato | The Benchmark Company | Sell |
| 2021-01-20 | Aggiornamento | UBS | Neutral → Buy |
| 2021-01-20 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2020-10-21 | Reiterato | BMO Capital Markets | Outperform |
| 2020-10-21 | Reiterato | Bernstein | Outperform |
| 2020-10-21 | Reiterato | Jefferies | Buy |
| 2020-10-21 | Reiterato | Morgan Stanley | Overweight |
| 2020-10-21 | Reiterato | Oppenheimer | Outperform |
| 2020-10-21 | Reiterato | Piper Sandler | Overweight |
| 2020-10-21 | Reiterato | Pivotal Research Group | Buy |
| 2020-10-21 | Reiterato | RBC Capital Mkts | Outperform |
| 2020-10-21 | Reiterato | The Benchmark Company | Sell |
| 2020-10-21 | Reiterato | Wedbush | Underperform |
| 2020-10-21 | Reiterato | Wells Fargo | Equal Weight |
| 2020-10-16 | Reiterato | Morgan Stanley | Overweight |
| 2020-10-15 | Reiterato | Canaccord Genuity | Buy |
| 2020-10-14 | Reiterato | Goldman | Buy |
| 2020-10-07 | Reiterato | Pivotal Research Group | Buy |
| 2020-09-28 | Reiterato | The Benchmark Company | Sell |
| 2020-09-15 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-09 | Ripresa | Raymond James | Mkt Perform |
| 2020-09-04 | Reiterato | The Benchmark Company | Sell |
| 2020-07-29 | Reiterato | Loop Capital | Buy |
Mostra tutto
Netflix Inc Borsa (NFLX) Ultime notizie
Netflix Threatens ByteDance With ‘Immediate Litigation’ Over Seedance 2.0 AI Clips - IMDb
Star Search Winner Revealed: Magician Tj Salta Wins $500,000 in Live Netflix Finale - IMDb
Netflix’s Live-Action ‘Scooby-Doo’ Series Finds Its Daphne In Mckenna Grace - Bloody Disgusting
Looking At The Evolving Narrative For Netflix (NFLX) After Target Resets And Warner Talks - Yahoo Finance Singapore
Netflix opens new Mexico headquarters for 400-strong workforce - Screen Daily
Netflix Warner Bros Bid Faces Paramount Challenge And Rising Scrutiny - Yahoo Finance
Warner Bros. gives Paramount one week to outbid Netflix - ABS-CBN
Gary Black Sees Warner Bros Deal Uncertainty As ‘Overhang’ On Netflix Stock - Asianet Newsable
Warner Bros reopens takeover talks with Paramount after receiving a waiver from Netflix - WTOP
Warner Bros. Discovery reopens bidding, gives Paramount seven days to make its case - Los Angeles Times
CNBC Exclusive: Transcript: Netflix Co-CEO Ted Sarandos Speaks with CNBC’s Julia Boorstin on “Closing Bell: Overtime” Today - CNBC
Warner Bros. Reopens Talks as Paramount Signals Higher Bid - Bloomberg.com
Warner Bros. Discovery: Acquisition Talks Reopened for Paramount as Vote on Netflix Offer Is Set - Morningstar
David Ellison Warns Senate Committee That Netflix Deal Would “Extinguish” Competition; Paramount CEO’s Letter Does Not Answer Queries About Trump - Yahoo Finance
Netflix's Live-Action 'Scooby-Doo' Series Casts the 'Perfect' Daphne - Parade
Negotiations continue for Netflix - Morningstar Australia
‘Scooby-Doo’ Live-Action Series Casts Mckenna Grace as Daphne: Netflix and Berlanti Productions Bet Big on Mystery Inc. - The TV Cave
Warner Bros. reopening takeover talks with Paramount, but Netflix deal still favoured - CBC
Mckenna Grace has landed the first major role in the upcoming live-action #ScoobyDoo series from Berlanti Productions and Netflix. Sources say she will play Daphne in the eight-episode series. Written by Midnight Radio’s Josh Appelbaum & Scott Rosenber - Facebook
How a ‘Stranger Things’ Star’s Netflix Journey Morphed into a Tragic ‘Industry’ Twist - IMDb
‘The Lincoln Lawyer’ Dethrones ‘Bridgerton’ as Netflix’s Most-Watched TV Show of the Week With 9.6 Million Views - IMDb
‘Scooby-Doo’ Live-Action Netflix Series Casts Mckenna Grace as Daphne - IMDb
Warner Bros Discovery backs Netflix merger while reopening Paramount talks - RNZ
Netflix (NFLX) Valuation Check After Recent Share Price Weakness And Long Term Return Strength - Yahoo Finance
Warner Bros. Activist Investor Praises Board, Netflix for Reopening ‘Necessary Discussions’ With Paramount Skydance - IMDb
How Low Can Netflix Stock Go After Its 16% Slide? - techi.com
Today's Stock on Wall StreetWarner Bros keeps Paramount and Netflix guessing - marketscreener.com
The Netflix-Paramount-Warner Bros. Three-Way Drama Just Keeps Heating Up - Investopedia
Netflix Execs Released A Snarky Statement About Paramount Over The Warner Bros Deal - Yahoo Finance
Warner Bros. CEO David Zaslav’s real plan was to let Paramount, Netflix ‘duke it out’: sources - Yahoo Finance
Ronda Rousey and Gina Carano to face off for Netflix’s 1st live MMA fight - FOX 2
Netflix slammed Paramount’s “antics” and blasted David Ellison's company for misleading Warner Bros. Discovery shareholders on regulatory issues. Read more below. - Facebook
Wham! Paramount Has 7 Days To Derail Netflix; Where Things Stand In The Brawl Over WBD - Yahoo Finance
Netflix stock slips as Warner Bros opens a brief window for Paramount to top its deal - Bez Kabli
Warner Bros. and Paramount Restart Merger Talks. Why Netflix Agreed. - Barron's
Paramount has final chance to snatch Warner Bros from Netflix - The Times
Paramount has 7 days to raise its offer for Warner Bros. after Netflix waives exclusivity - Fortune
Warner Bros rejects revised Paramount bid, but remains open to a final offer - The Detroit News
Here’s why Netflix would still win the race for WBD assets - Invezz
Warner Bros. Reopens Talks With Paramount, Sets Date For Netflix-Sale Vote - Yahoo Finance
Netflix gives Warner Bros. Discovery 7-day waiver to resume merger talks with Paramount - Anadolu Ajansı
Warner Bros. Discovery to resume talks with Paramount despite Netflix deal - Yahoo Finance
Netflix grants 7-day window for WBD-Paramount offer discussions - Yahoo! Finance Canada
‘Not the Only Game in Town,’ Says Top Investor About Netflix Stock - TipRanks
Gaumont’s Berlin-Set Spy Thriller ‘Unfamiliar’ Shoots to Top Spot on Netflix - IMDb
Subscription Prices Are Going Up Again - The Motley Fool
Warner Bros gives Paramount seven days to make ‘best and final’ offer - The Guardian
Warner Bros. Discovery Restarts Deal Talks With Paramount - The New York Times
Netflix, Inc. (NFLX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Warner Bros received Netflix's permission for new merger talks with Paramount - Українські Національні Новини (УНН)
WBD Stock Gains as Paramount Pressures Warner Ahead of Netflix Merger Vote - TipRanks
Netflix Inc Azioni (NFLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.01%
2.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):